Ticker Short Interest

KIDS Short Interest Intelligence

Orthopediatrics Corp positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Shorts Under Pressure

KIDS is classified as Neutral. Latest reported short interest is 895.5K shares; short interest changed +5.5%, price moved +13.9% since the previous report, short interest is in the 43th percentile, and days to cover is in the 29th percentile. Trend context is constructive.

Setup Score57/100Neutral
Reported Short Interest895.5K+5.5% vs prior report
Days To Cover4.9328.57 percentile
Price Reaction+13.9%since previous short report
Squeeze Pressure57crowding, trend, and pressure
Bearish Conviction22shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

57

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

22

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

36

Latest short interest is 895.5K shares and days to cover is 4.93.

Divergence

40

Short interest rose while price rose. Bearish positioning is adding into strength, which can create squeeze pressure if the chart keeps improving.

Report History

KIDS Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 895491 849175 5.5% 4.93 181732
15 Jun 2026 849175 912367 -6.9% 6.91 122957
29 May 2026 912367 947277 -3.7% 7.61 119937
15 May 2026 947277 890766 6.3% 4.45 212945
30 Apr 2026 890766 944283 -5.7% 5.07 175848
15 Apr 2026 944283 965855 -2.2% 6.95 135804
31 Mar 2026 965855 948112 1.9% 4.98 193891

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.